...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>The journal of alternative and complementary medicine: research on paradigm, practice, and policy >Adherence to CONSORT Items in Randomized Controlled Trials of Integrative Medicine for Colorectal Cancer Published in Chinese Journals
【24h】

Adherence to CONSORT Items in Randomized Controlled Trials of Integrative Medicine for Colorectal Cancer Published in Chinese Journals

机译：在中国期刊上发表的结肠直肠癌综合癌症随机对照试验中的依据

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Background: The majority of studies of integrative treatment for colorectal cancer (CRC) have been published in Chinese journals. These studies indicate potential benefits, but concerns have been raised over the quality of trials published in Chinese journals. The CONSORT statement provides a guide for study reporting that has been endorsed by more than 400 international journals. Previous studies have used the CONSORT checklist to assess the quality of randomized controlled trials (RCTs). Objectives: This study focused on RCTs of integrative and traditional medicine for CRC published in Chinese journals and assessed: (1) the overall quality of reporting with a focus on methodological aspects; (2) change over time; and (3) the influence of study funding, level of institution conducting the trial, rank of the journal, and the length of the article. Design: Searches of seven databases identified RCTs. Quality was assessed using CONSORT 2010 with adaptations to facilitate scoring. Additional codes were added for publication year, hospital rank, report length, and status of the journal. Scores of each checklist item, total scores, and scores for eight items associated with RCT methodology were calculated. Results: Eighty-one studies were included in the main analyses. The RCT methodology subgroup scores were significantly higher in studies: with public funding, conducted by authors from university hospitals, published in higher ranked journals, and in longer articles. Conclusions: Few Chinese journals mention CONSORT in their author guidelines. In these RCTs on CRC better reporting of RCT methodology was associated with ranking of the journal as “core,” public funding of the RCT, and first or correspondent author from a university hospital but the quality of reporting had not significantly improved in 15 years. As the volume of scientific information produced in China grows, it is imperative that there is growth in the quality of this information.
机译：背景：结直肠癌（CRC）的整合治疗的大部分研究已发表在中国期刊上。这些研究表明潜在的福利，但对中国期刊发表的审判质量提出了担忧。联盟陈述为学习报告指南提供了超过400多个国际期刊的认可。以前的研究已经使用了联盟清单来评估随机对照试验的质量（RCT）。目的：本研究侧重于中国期刊发布的CRC综合和传统医学的RCT，并评估：（1）报告的整体质量，重点是方法论方面; （2）随着时间的推移而变化; （3）研究资金的影响，进行审判的机构水平，日志等级和文章的长度。设计：七个数据库的搜索标识到RCT。使用2010年的补编评估质量，适应促进得分。出版年份，医院等级，报告长度和日志状态增加了附加代码。计算了每个清单项目，总分数和与RCT方法相关的八个项目的分数的分数。结果：八十一项研究含有主要分析。 RCT方法亚组分数在研究中显着提高：随着大学医院的作者进行的公共资金，在较高的排名期刊上发表，并且在更长的文章中。结论：少数中国期刊在作者指南中提到了联合会。在这些CRC上的RCT，RCT方法的更好报告与日志的排名相关，作为“核心，”RCT的公共资金，以及大学医院的第一或记者作者，但报告质量在15年内没有明显改善。随着中国生产的科学信息量的增长，必须必须有这种信息的质量增长。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号